A breast cancer screening system using deep learning algorithms that can quickly and accurately identify breast tumors and determine their benign or malignant nature. The system enables rapid and precise localization of breast lesions.
Manufactured by
Hangzhou Precision MedCare co.LTD
China
Hangzhou Precision MedCare is a digital healthcare company founded in 2019, specializing in AI and cloud computing applications for medical services. The company has developed proprietary thyroid and breast screening technology that has served over 2 million residents across 105 communities in China. It holds 2 Class II medical device registration certificates, 6 invention patents, and is recognized as a national technology-based SME.
© 2026 Suplivia · Home · Browse Products